| William Lovejoy, DPT | |
|
1 Greenwood Ave, Montclair, NJ 07042-3649 | |
| (973) 746-2424 | |
| Not Available |
| Full Name | William Lovejoy |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 1 Greenwood Ave, Montclair, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144839051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Occupational And Physical Therapy Pllc | 3779873401 | 518 |
News Archive
A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2010.
› Verified 8 days ago
| Provider Name | Rothman Orthopaedics Of New Jersey, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215978630 PECOS PAC ID: 6709864846 Enrollment ID: O20040713001385 |
News Archive
A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2010.
› Verified 8 days ago
| Provider Name | Professional Occupational & Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1215487772 PECOS PAC ID: 3779873401 Enrollment ID: O20170118000654 |
News Archive
A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2010.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Lovejoy, DPT 576 Broadhollow Rd, Melville, NY 11747-5002 Ph: (631) 359-5859 | William Lovejoy, DPT 1 Greenwood Ave, Montclair, NJ 07042-3649 Ph: (973) 746-2424 |
News Archive
A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2010.
› Verified 8 days ago
Ms. Barbara Carol Foley, P.T., F.P. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 232 Grove St, Montclair, NJ 07042 Phone: 973-746-9415 | |
Shaun Astorga, Physical Therapist Medicare: Medicare Enrolled Practice Location: 15 Bloomfield Ave, Montclair, NJ 07042 Phone: 973-744-2770 | |
Ms. Laura Ann Crandall, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 267 Park St, Montclair, NJ 07043 Phone: 973-744-8205 | |
Ms. Suzanne Goodman, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 19 Elm St, Montclair, NJ 07042 Phone: 973-798-6800 Fax: 973-798-6801 | |
Professional Orthopedic And Sports Physical Therapy Of Nj, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 691 Bloomfield Ave, Montclair, NJ 07042 Phone: 973-893-5082 | |
David Kwon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 15 Bloomfield Ave, Lower Level, Montclair, NJ 07042 Phone: 973-744-2770 | |
Michael Joseph Habersaat, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Greenwood Ave, Montclair, NJ 07042 Phone: 973-746-2424 |